rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCATTACCCTGCCGGATTACAGGGGCGCAACGTATGGCTACACCTTCGGTTCG	CASITLPDYRGATYGYTF	In	VDJ	1	130	0.004050348953140578	0.005302010685590767	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	5	15	7	23	33	55	48	62			01,02										Vb 1	CASITLPDYRGATYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCCCCTCAGCAGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CASSPQQGTNEKLFF	In	VDJ	1	155	0.00482926221335992	0.006321628125127452	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	2	9	1	23	32	46	41	47			01,02										Vb 1	CASSPQQGTNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAACCAAGCATTATTAGGGAGCTGGGGCTACACCTTCGGTTCG	CASSQNQALLGSWGYTF	In	VDJ	1	65	0.002025174476570289	0.0026510053427953833	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	2	8	15	4	29	44	64	59	68													Vb 16	CASSQNQALLGSWGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCTAGCAGCCAACTATACGGCCAAGAGACCCAGTACTTCGGGCCA	CASSQLYGQETQYF	In	VDJ	3	431	0.013428464606181455	0.017578204657612465	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	9	1	0	5	29	-1	47	44	52						01,02							Vb 16	CASSQLYGQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGGCGGGAGTTCCTACGAGCAGTACTTCGGGCCG	CAWRGGSSYEQYF	In	VDJ	1	45	0.0014020438683948156	0.0018353113911660345	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	1	2	1	26	37	46	39	47			unresolved										Vb 20	CAWRGGSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGAGTGTTAGCGGGAGCGTCGCCTACGAGCAGTACTTCGGGCCG	CVWSVSGSVAYEQYF	In	VDJ	1	48	0.0014955134596211367	0.001957665483910437	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	2	2	0	5	26	-1	49	40	54			unresolved										Vb 20	CVWSVSGSVAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCGGACAATACTAATGAAAAACTGTTTTTTGGCAGT	CAWTPDNTNEKLFF	In	VDJ	1	56	0.001744765702891326	0.0022839430645621764	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	6	2	4	2	26	36	45	40	47													Vb 20	CAWTPDNTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCCGAATAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRINTGELFF	In	VDJ	3	394	0.01227567298105683	0.01606917084709817	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	7	2	8	2	3	3	26	33	38	36	41			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASRINTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGGGACAGTCTCCTACGAGCAGTACTTCGGGCCG	CAWSLGTVSYEQYF	In	VDJ	7	1031	0.03212238285144566	0.042049023206492925	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	0	3	1	26	38	48	41	49			unresolved										Vb 20	CAWSLGTVSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACCCAGCGGGAGGGCCACGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	67	0.0020874875373878363		46	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	0	10	3	6	23	38	51	41	57														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGAAACTAGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQEETSGSSYEQYF	In	VDJ	3	378	0.011777168494516451	0.01541661568579469	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	2	0	4	0	23	40	-1	44	55														CASSQEETSGSSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGACAGGGGACGGTCTACGAGCAGTACTTCGGGCCG	CASSSGQGTVYEQYF	In	VDJ	1	41	0.0012774177467597208	0.0016721726008401647	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	3	2	5	19	32	43	34	48													Vb 5.1	CASSSGQGTVYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTACGGGACAGGGTGCCTACGAGCAGTACTTCGGGCCG	CASSPTGQGAYEQYF	In	VDJ	1	43	0.0013397308075772682	0.0017537419960030997	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	5	2	19	31	45	36	47													Vb 5.1	CASSPTGQGAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGCTAGCGGGAGCCCATACACAGATACGCAGTATTTTGGCCCA	CASSSASGSPYTDTQYF	In	VDJ	1	92	0.0028664007976071785	0.003752192177495004	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	2	3	6	19	32	45	35	51													Vb 5.1	CASSSASGSPYTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCTTATGCGGGAGGCGGGCAAGATACGCAGTATTTTGGCCCA	CASSLAYAGGGQDTQYF	In	VDJ	1	97	0.0030221834496510468	0.003956115665402341	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	1	5	5	6	19	35	48	40	54													Vb 5.1	CASSLAYAGGGQDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTGAGGGAAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGNSGANVLTF	In	VDJ	1	122	0.003801096709870389	0.004975733104939027	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	0	0	1	3	19	30	36	31	39													Vb 5.1	CASSEGNSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TCGGCCCTTTATCTTTGCGCCAGCAGCTTGTAACTAGAAAGAAGGGGTACCTGCCTTAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSL*LERRGTCLNSYNEQFF	Stop	VDJ	1	134	0.004174975074775673		66	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	1	5	2	0	12	12	15	30	47	42	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSL*LERRGTCLNSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	80	0.0024925224327018943		47	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	3	3	6	5	5	5	25	39	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGAGTAGCGGGGGTGGCGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	123	0.0038322532402791623		52	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	5	2	2	4	6	25	41	54	45	60													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGACCAAGACCATCCTACGAGCAGTACTTCGGGCCG	CASRGPRPSYEQYF	In	VDJ	2	267	0.008318793619142572	0.010889514254251805	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	1	7	1	1	8	25	36	41	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRGPRPSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAAGGATGACTACGAGCAGTACTTCGGGCCG	CASSKDDYEQYF	In	VDJ	2	274	0.008536889332003987	0.011175007137322076	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	1	8	3	2	3	25	37	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSKDDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTGAAGGCGGGAGTGGTGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	65	0.002025174476570289		52	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	7	2	1	4	4	23	39	50	43	54													Vb 12	X+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGTGGGGGGCGTACGCAGTATTTTGGCCCA	CASSESGGRTQYF	In	VDJ	1	98	0.0030533399800598206	0.003996900362983808	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	2	6	0	8	4	1	23	38	48	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGGRTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGGGGCGCAATGTGAATGAGCAGTTCTTCGGGCCA	CASRGRNVNEQFF	In	VDJ	1	46	0.0014332003988035893	0.001876096088747502	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	4	0	7	0	8	27	-1	43	35	51			01,02										Vb 17	CASRGRNVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGCGGGAGTCCTGGGATGAGCAGTTCTTCGGGCCA	CASSARESWDEQFF	In	VDJ	1	50	0.001557826520438684	0.002039234879073372	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	8	2	7	27	39	48	41	55			01,02										Vb 17	CASSARESWDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCAGCACAGGTGAACATTGAAGCTTTCTTTGGACAA	CASSAQVNIEAFF	In	VDJ	1	54	0.0016824526420737786	0.0022023736693992414	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	4	7	5	7	27	36	46	41	53			01,02										Vb 17	CASSAQVNIEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTTTTGGGATGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSFGMSNQPQHF	In	VDJ	1	59	0.001838235294117647	0.0024062971573065787	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	8	1	5	2	27	40	49	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSFGMSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGGGGGCTGAAGATACGCAGTATTTTGGCCCA	CASSIKGAEDTQYF	In	VDJ	1	59	0.001838235294117647	0.0024062971573065787	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	0	5	1	3	27	42	50	43	53			01,02										Vb 17	CASSIKGAEDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGCGGGAGGGTTGCAGATACGCAGTATTTTGGCCCA	CASSISGRVADTQYF	In	VDJ	1	59	0.001838235294117647	0.0024062971573065787	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	0	4	0	3	27	-1	52	41	55			01,02										Vb 17	CASSISGRVADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTATCGACCAAATCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	60	0.0018693918245264206		49	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	2	7	4	5	13	27	39	47	44	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGACGGGCGGCACTGAAGCTTTCTTTGGACAA	CASSLTGGTEAFF	In	VDJ	1	77	0.0023990528414755733	0.0031404217137729925	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	8	0	4	6	2	27	38	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLTGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGAGACCTACAATGAGCAGTTCTTCGGGCCA	CASSIRETYNEQFF	In	VDJ	1	110	0.0034272183449651048	0.004486316733961417	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	2	1	1	27	41	48	42	49			01,02										Vb 17	CASSIRETYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACACCTGAGGGGGGTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	125	0.00389456630109671		46	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	5	1	5	8	3	27	39	53	47	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGACGGTCTCTGGAAACACCATATATTTTGGAGAG	CASRTVSGNTIYF	In	VDJ	2	252	0.007851445663010968	0.010277743790529793	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	9	1	7	0	2	3	27	35	41	37	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTVSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGCGGGGGGTCGGAATGAAAAACTGTTTTTTGGCAGT	CASAGGRNEKLFF	In	VDJ	3	473	0.01473703888334995	0.019291161956034097	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	9	7	1	5	1	4	27	35	44	36	48			01,02										Vb 17	CASAGGRNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCTTTGGACAGGAGCCTATGGCTACACCTTCGGTTCG	CASSDLWTGAYGYTF	In	VDJ	1	97	0.0030221834496510468	0.003956115665402341	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	4	5	3	23	37	49	42	52													Vb 11	CASSDLWTGAYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCCTAGCGGGAGGAGGGTCGGGCACAGATACGCAGTATTTTGGCCCA	CSASPLAGGGSGTDTQYF	In	VDJ	1	42	0.0013085742771684946	0.0017129572984216322	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	1	1	4	8	26	37	52	41	60		TCRBV20-01,TCRBV20-or09_02												CSASPLAGGGSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGAGGGGTTATGAGCAGTTCTTCGGGCCA	CSARRGYEQFF	In	VDJ	1	43	0.0013397308075772682	0.0017537419960030997	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	8	2	3	26	34	42	36	45		TCRBV20-01,TCRBV20-or09_02												CSARRGYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGGCACCCAGGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLAPRGGYNEQFF	In	VDJ	1	43	0.0013397308075772682	0.0017537419960030997	48	unresolved						TCRBJ02	TCRBJ02-01	01	3	4	2	3	6	3	18	32	44	38	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPRGGYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCAGACTAGCGCTCCAAGAGACCCAGTACTTCGGGCCA	CSARPRLALQETQYF	In	VDJ	1	46	0.0014332003988035893	0.001876096088747502	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	2	6	1	4	2	26	38	50	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPRLALQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGGGGAGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	46	0.0014332003988035893		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	5	2	5	1	1	26	36	42	37	43		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCCCAGAAGCTGCTCGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	47	0.0014643569292123629		52	unresolved						TCRBJ02	TCRBJ02-06	01	8	3	6	5	15	5	18	27	45	42	50	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGACCCTGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CSARPWATGELFF	In	VDJ	1	49	0.0015266699900299103	0.001998450181491904	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	8	0	4	8	0	26	34	-1	42	46		TCRBV20-01,TCRBV20-or09_02												CSARPWATGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCAACGGCGCAGATACGCAGTATTTTGGCCCA	CASSQFNGADTQYF	In	VDJ	1	50	0.001557826520438684	0.002039234879073372	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	2	9	0	4	6	1	26	41	50	47	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFNGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTACCCTCAACCTGCGGGAGACCCAGTACTTCGGGCCA	CSATTLNLRETQYF	In	VDJ	1	51	0.0015889830508474577	0.002080019576654839	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	5	5	13	0	26	36	-1	49	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSATTLNLRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCAAGGACCCTAGCGGGAGGGCCGGGTATGAGCAGTTCTTCGGGCCA	CASSKDPSGRAGYEQFF	In	VDJ	1	53	0.001651296111665005	0.002161588971817774	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	8	7	6	18	30	49	37	55	TCRBV07,TCRBV11													CASSKDPSGRAGYEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTACAAGGTCGAAGAGACCCAGTACTTCGGGCCA	CASSQYKVEETQYF	In	VDJ	1	56	0.001744765702891326	0.0022839430645621764	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	3	3	6	3	2	6	26	40	45	42	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQYKVEETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCAGGTTCCCAGGGAAATTTGAACGAGCAGTACTTCGGGCCG	CSASSGSQGNLNEQYF	In	VDJ	1	57	0.0017759222333000996	0.0023247277621436437	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	5	10	8	26	37	52	47	60		TCRBV20-01,TCRBV20-or09_02												CSASSGSQGNLNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAGGAGGGGGGGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	58	0.0018070787637088734		38	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	9	0	7	7	1	26	34	48	41	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGATGTTTCCCATTTCTTTCTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	60	0.0018693918245264206		50	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	0	8	5	0	19	26	-1	42	38	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCTCATCCTTGGGGGCCAACGTCCTAACTTTCGGGGCC	CASSPSSLGANVLTF	In	VDJ	1	60	0.0018693918245264206	0.002447081854888046	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	6	0	19	11	10	24	36	53	47	63		TCRBV24-01,TCRBV24-or09_02												CASSPSSLGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCTCCCGACTAGCGGGAGTTACCCACGAGCAGTACTTCGGGCCG	CASSSSRLAGVTHEQYF	In	VDJ	1	61	0.0019005483549351945	0.0024878665524695133	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	2	5	6	6	18	31	49	37	55	TCRBV07,TCRBV11													CASSSSRLAGVTHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCGCCCAGAACACTGAAGCTTTCTTTGGACAA	CASSLAQNTEAFF	In	VDJ	1	63	0.001962861415752742	0.0025694359476324483	39	unresolved						TCRBJ01	TCRBJ01-01	01	4	4	6	1	5	0	23	36	-1	41	43	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAQNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACAACTAGCGGGAGACCAAAATGAGCAGTTCTTCGGGCCA	CASSLQLAGDQNEQFF	In	VDJ	1	67	0.0020874875373878363	0.002732574737958318	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	2	7	4	5	26	39	54	43	59		TCRBV03-01,TCRBV03-02												CASSLQLAGDQNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGCCAGACATCAGAAAGAGACCCAGTACTTCGGGCCA	CASSLARHQKETQYF	In	VDJ	1	68	0.00211864406779661	0.0027733594355397856	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	6	3	5	5	18	32	41	37	46	TCRBV07,TCRBV11													CASSLARHQKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACCACCAGGGGAAGGGAAGCCCTCACCGGGGAGCTGTTTTTTGGAGAA	CASTTRGREALTGELFF	In	VDJ	1	74	0.0023055832502492522	0.0030180676210285902	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	2	4	4	12	23	33	43	37	55	TCRBV24,TCRBV27													CASTTRGREALTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACGACTGTGTTAGACGAGCAGTACTTCGGGCCG	CASSPTTVLDEQYF	In	VDJ	1	76	0.0023678963110667995	0.003099637016191525	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	5	4	7	26	39	47	43	54		TCRBV03-01,TCRBV03-02				01,02								CASSPTTVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACGCGGGACACTCTCCCAAGAGACCCAGTACTTCGGGCCA	CSARGRGTLSQETQYF	In	VDJ	1	83	0.0025859920239282154	0.003385129899261797	48	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	0	6	1	5	5	26	39	50	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGRGTLSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGCATCAGCCCCAGCATTTTGGTGAT	CASSRHQPQHF	In	VDJ	1	84	0.002617148554336989	0.0034259145968432644	33	TCRBV03						TCRBJ01	TCRBJ01-05	01	5	5	4	5	0	1	26	-1	41	38	42		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRHQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGAGCCGTAGCAGGACACCTCTATGCAGTACTTCGGGCCG		Out	VDJ	1	85	0.0026483050847457626		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	6	9	11	7	24	31	47	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGAGACCCCTACGAGCAGTACTTCGGGCCG	CASSLAGDPYEQYF	In	VDJ	1	85	0.0026483050847457626	0.0034666992944247317	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	2	2	0	3	18	-1	40	35	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGDPYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAAATCAGGAGGAGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	86	0.0026794616151545364		46	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	0	2	9	0	26	37	-1	46	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAGGGGAGGCTGAAGCTTTCTTTGGACAA	CSASGEAEAFF	In	VDJ	1	87	0.0027106181455633102	0.0035482686895876667	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	4	2	6	1	3	26	35	42	36	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGEAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGCGACAGGGTATGCGTGAGCAGTACTTCGGGCCG	CATSDSRQGMREQYF	In	VDJ	1	91	0.0028352442671984047	0.0037114074799135363	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	7	3	7	24	40	50	43	57		TCRBV24-01,TCRBV24-or09_02												CATSDSRQGMREQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGAACACCGGAGACGGGGAGGGCTACACCTTCGGTTCG	CASRNTGDGEGYTF	In	VDJ	1	97	0.0030221834496510468	0.003956115665402341	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	3	8	12	2	23	34	51	46	53	TCRBV02,TCRBV09					01,02								CASRNTGDGEGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCTGAGCCCTACCCTTGACCACAGATACGCAGTATTTTGGCCCA	CASSLA*ALPLTTDTQYF	Stop	VDJ	1	101	0.0031468095712861416		54							TCRBJ02	TCRBJ02-03	01	0	2	7	2	15	0	18	35	-1	50	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLA*ALPLTTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTGGGTCCCAATGAGCAGTTCTTTGGGCCA	CSASLGPNEQFF	In	VDJ	1	106	0.00330259222333001	0.004323177943635548	36	TCRBV20						TCRBJ02			3	0	9	22	3	19	26	37	43	40	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CSASLGPNEQFF+TCRBV20-X+TCRBJ02-X	TCRBV20		TCRBJ02	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACAAAGCGGGAGGGTTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	108	0.003364905284147557		46	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	0	2	4	2	26	38	52	42	54		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCAGGGACGAAACAGATACGCAGTATTTTGGCCCA	CASSRDETDTQYF	In	VDJ	1	111	0.003458374875373878	0.004527101431542885	39	unresolved						TCRBJ02	TCRBJ02-03	01	4	0	7	3	1	3	23	35	41	36	44	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDETDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTGGGTGGGATGAGCAGTTCTTCGGGCCA	CASSQGGWDEQFF	In	VDJ	1	113	0.003520687936191426	0.00460867082670582	39	unresolved						TCRBJ02	TCRBJ02-01	01	1	0	9	8	2	4	23	39	44	41	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGWDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGAGAGGTAAAGCTTTCTTTGGACAA	CASSQARGKAFF	In	VDJ	1	114	0.003551844466600199	0.0046494555242872875	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	1	9	3	2	26	42	49	45	51		TCRBV03-01,TCRBV03-02												CASSQARGKAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCATCGGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CAIGTSGTDTQYF	In	VDJ	1	116	0.003614157527417747	0.004731024919450222	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	0	6	1	2	0	26	33	-1	35	45		TCRBV03-01,TCRBV03-02				01,02								CAIGTSGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGCCGGGACAGGGAAGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	128	0.003988035892323031		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	6	4	5	26	36	49	40	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCTTGGCGATCATAGTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	149	0.004642323030907278		47	unresolved						TCRBJ01	TCRBJ01-02	01	8	2	7	4	19	0	18	27	-1	46	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCCGGGAATATACCAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	161	0.005016201395812562		55	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	8	3	5	2	16	24	36	43	38	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01*02	TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCCGGGACAGGGTCTTCTTACGAGCAGTACTTCGGGCCG	CSARGAGTGSSYEQYF	In	VDJ	1	163	0.00507851445663011	0.006647905705779192	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	4	5	6	26	39	53	44	59		TCRBV20-01,TCRBV20-or09_02												CSARGAGTGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACTAGCGAAAACACAGATACGCAGTATTTTGGCCCA	CSAGTSENTDTQYF	In	VDJ	1	174	0.0054212362911266205	0.0070965373791753335	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	2	0	4	26	-1	45	35	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGTSENTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATGCATAGTTTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	176	0.005483549351944167		50	TCRBV20						TCRBJ02	TCRBJ02-06	01	5	3	6	5	13	5	26	35	51	48	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGGTTCGTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	178	0.005545862412761715		46	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	5	3	1	2	6	26	40	46	42	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTCGTAGCGGGAGGCCAGGGGGAGCAGTACTTCGGGCCG	CASSFVAGGQGEQYF	In	VDJ	1	181	0.005639332003988036	0.007382030262245606	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	1	7	2	7	26	40	52	42	59		TCRBV12-03,TCRBV12-04												CASSFVAGGQGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTTATAGGAGGGGGTCCGAACACTGAAGCTTTCTTTGGACAA	CASSLIGGGPNTEAFF	In	VDJ	1	216	0.006729810568295114	0.008809494677596966	48	unresolved						TCRBJ01	TCRBJ01-01	01	4	5	1	1	7	3	23	36	49	43	52	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGGGPNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCGACGGGAGCCTTCGAACAGTACTTCGGGCCG	CASSPTGAFEQYF	In	VDJ	1	218	0.006792123629112662	0.008891064072759901	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	2	10	5	8	26	37	48	42	56		TCRBV03-01,TCRBV03-02												CASSPTGAFEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCCCCAGGACCAACACTGAAGCTTTCTTTGGACAA	CASSQGPRTNTEAFF	In	VDJ	2	232	0.007228315054835494	0.009462049838900444	45	unresolved						TCRBJ01	TCRBJ01-01	01	1	1	7	2	6	1	23	39	49	45	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGPRTNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGTCGGCGGGGCGCCTAGTGGAGCAGTACTTCGGGCCG		Out	VDJ	2	245	0.007633349950149551		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	7	5	9	18	32	43	37	52	TCRBV05,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCGGACTAGCGGGAGTGGGGAGACCCAGTACTTCGGGCCA	CASSPRTSGSGETQYF	In	VDJ	2	247	0.007695663010967099	0.010073820302622456	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	1	2	5	4	4	24	36	53	40	57		TCRBV24-01,TCRBV24-or09_02												CASSPRTSGSGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGCGGGAGTTGGGCAGTTCTTCGGGCCA	CASSPAGVGQFF	In	VDJ	2	255	0.007944915254237288	0.010400097883274196	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	2	12	1	4	26	39	48	40	52		TCRBV03-01,TCRBV03-02												CASSPAGVGQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGACTCGGACTGGCCAGATACGCAGTATTTTGGCCCA	CASSDSDWPDTQYF	In	VDJ	2	280	0.00872382851445663	0.011419715322810881	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	4	5	3	26	38	48	43	51		TCRBV12-03,TCRBV12-04				01,02								CASSDSDWPDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGGGGAGTCTGCAGCCCCAGCATTTTGGTGAT	CSALGSLQPQHF	In	VDJ	2	296	0.009222333000997009	0.012072270484114361	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	2	7	4	4	26	34	43	38	47		TCRBV20-01,TCRBV20-or09_02												CSALGSLQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAACCTATTGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	413	0.012867647058823529		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	4	9	6	4	3	23	37	44	41	47	TCRBV01,TCRBV04					01,02								X+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTACAGTGGCAGCAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	3	447	0.013926969092721835		53	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	5	22	34	50	46	55		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAACTAAGCGGGAGGGCCGGGGAGACCCAGTACTTCGGGCCA	CASSELSGRAGETQYF	In	VDJ	3	471	0.014674725822532403	0.01920959256087116	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	6	0	5	3	5	23	38	51	41	56	TCRBV02,TCRBV12													CASSELSGRAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGGCACCGGAGACCTAGTACTTCGGGCCA	CASSPAPET*YF	Stop	VDJ	3	474	0.014768195413758723		36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	10	2	12	9	4	24	35	48	44	52		TCRBV24-01,TCRBV24-or09_02												CASSPAPET*YF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGAGGGCGATATAGGAGACGTCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGDIGDVDTGELFF	In	VDJ	4	517	0.016107926221335993	0.021085688649618663	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	0	3	1	17	26	37	43	38	60		TCRBV03-01,TCRBV03-02												CASSEGDIGDVDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGCTGAGGGGGACTACGAGCAGTACTTCGGGCCG	CSGAEGDYEQYF	In	VDJ	4	526	0.016388334995014957	0.02145275092785187	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	1	3	6	1	26	33	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSGAEGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGAGTCCGGGGTTTTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	532	0.016575274177467597		46	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	3	3	6	4	26	40	51	46	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGAACTAGCGGGATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	536	0.01669990029910269		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	3	3	3	1	26	39	52	42	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGATTGAGCGAGCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSIERANTGELFF	In	VDJ	4	559	0.017416500498504486	0.022798645948040295	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	6	6	2	10	4	24	36	50	46	54	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSIERANTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGTAGGCGGGGGGCTAGCGGGTCGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	6	849	0.026451894317048853		55	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	4	6	12	5	23	37	57	49	62	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATTACGGCTCCCATCGTGTTAGACGAGCAGTACTTCGGGCCG	CASSITAPIVLDEQYF	In	VDJ	6	920	0.028664007976071784	0.03752192177495004	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	9	0	5	5	14	26	38	46	43	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSITAPIVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGAGCGGGAGTGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CSARSGSGPYNEQFF	In	VDJ	6	945	0.029442921236291126	0.03854153921448673	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	2	2	4	5	26	34	46	38	51		TCRBV20-01,TCRBV20-or09_02												CSARSGSGPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAATCTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQNLAGGTDTQYF	In	VDJ	7	1039	0.03237163509471585	0.04237530078714467	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	1	4	0	23	37	-1	41	51	TCRBV01,TCRBV04													CASSQNLAGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGAAACGGAGCGGGGTGGAGGGAAGATACGCAGTATTTTGGCCCA	CSVRNGAGWREDTQYF	In	VDJ	1	45	0.0014020438683948156	0.0018353113911660345	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	3	5	9	8	25	33	49	42	57													Vb 4	CSVRNGAGWREDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGACTTGGACAGGGACTGACTGAAGCTTTCTTTGGACAA	CSGLGQGLTEAFF	In	VDJ	1	46	0.0014332003988035893	0.001876096088747502	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	3	5	5	4	25	32	45	37	49													Vb 4	CSGLGQGLTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCACCAGGACAGCTCAATGAGCAGTTCTTCGGGCCA	CSASPGQLNEQFF	In	VDJ	1	49	0.0015266699900299103	0.001998450181491904	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	5	6	8	2	25	32	46	40	48													Vb 4	CSASPGQLNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAGTGGGGTTAGCACAGATACGCAGTATTTTGGCCCA	CSVESGVSTDTQYF	In	VDJ	1	66	0.002056331006979063	0.0026917900403768506	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	2	6	2	0	3	2	25	37	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVESGVSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCGGAAAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVEAEKNTGELFF	In	VDJ	1	108	0.003364905284147557	0.004404747338798483	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	1	1	8	1	1	3	25	38	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEAEKNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCATGGGCGGAGGGCCAGGCTACAATGAGCAGTTCTTCGGGCCA	CMGGGPGYNEQFF	In	VDJ	1	173	0.005390079760717846	0.007055752681593866	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	10	0	3	5	5	25	29	40	34	45													Vb 4	CMGGGPGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCGGGAGCTGGGATACGCAGTATTTTGGCCCA	CSVGGSWDTQYF	In	VDJ	2	238	0.007415254237288136	0.009706758024389249	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	2	6	0	4	25	-1	42	35	46													Vb 4	CSVGGSWDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCAGGGACAACTATGGCTACACCTTCGGTTCG	CSVVPRDNYGYTF	In	VDJ	5	695	0.02165378863409771	0.028345364819119867	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	2	6	0	25	35	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVPRDNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGTCCGGGCAGTCAGCCCCAGCATTTTGGTGAT	CASGPGSQPQHF	In	VDJ	1	54	0.0016824526420737786	0.0022023736693992414	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	8	8	0	6	5	2	23	32	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASGPGSQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGACGGGGGGTTTGAAGCTTTCTTTGGACAA	CASRDGGFEAFF	In	VDJ	1	116	0.003614157527417747	0.004731024919450222	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	7	3	2	23	34	44	37	46													Vb 22	CASRDGGFEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCTAGCGGGAATATGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	241	0.007508723828514457		49	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	3	0	1	6	23	35	45	36	51													Vb 22	X+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCATTCTAGAGGGTCTACCGGCGAAACACCATATATTTTGGAGAG		Out	VDJ	1	72	0.002243270189431705		46	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	11	0	5	5	9	23	33	43	38	52		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCTCCCTCGGTAGAAAAACTGTTTTTTGGCAGT	CASSSPSVEKLFF	In	VDJ	1	126	0.003925722831505484	0.005138871895264897	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	5	8	6	2	23	36	45	42	47		TCRBV06-07,TCRBV06-08				01,02								CASSSPSVEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCACCCGGACGAGGGGGAACGCAGTATTTTGGCCCA		Out	VDJ	1	139	0.004330757726819541		37	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	1	9	8	1	23	33	47	41	48		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCGAAGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSRRGGETQYF	In	VDJ	3	372	0.01159022931206381	0.015171907500305885	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	4	6	0	23	34	-1	40	46		TCRBV06-04,TCRBV06-08												CASSRRGGETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTTCGACAGGGAGGGGTGGGGGAGCAGTACTTCGGGCCG	CASSLRQGGVGEQYF	In	VDJ	1	136	0.00423728813559322	0.005546718871079571	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	4	2	3	7	3	10	23	36	46	39	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSLRQGGVGEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCACGAGAAGGGGCAATGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	0.0014020438683948156		46	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	2	1	5	6	26	36	46	41	52			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD01-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGACTAGCGGGTAAATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	0.0014020438683948156		41	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	4	4	0	4	26	-1	48	40	52			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCGCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	69	0.002149800598205384		37	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-02	01	6	2	7	4	7	0	26	37	-1	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ01-02	TCRBV10-01		TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGGGACAGTAGGATGAACACTGAAGCTTTCTTTGGACAA	CARDSRMNTEAFF	In	VDJ	2	262	0.008163010967098703	0.010685590766344467	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	1	5	0	0	5	26	-1	40	34	45			01,02										Vb 12	CARDSRMNTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTCCCGGACAGTCTGAACACTGAAGCTTTCTTTGGACAA	CATSRVPDSLNTEAFF	In	VDJ	1	73	0.0022744267198404784	0.0029772829234471225	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	5	0	4	2	18	34	44	38	46														CATSRVPDSLNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGAAATGAGGGGAACCCAGTACTTCGGGCCA	CATSRVEMRGTQYF	In	VDJ	2	353	0.010998255234297108	0.014396998246258005	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	1	5	2	8	8	1	18	34	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVEMRGTQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGACAGAGGAGCTTACTACGAGCAGTACTTCGGGCCG	CASSSDRGAYYEQYF	In	VDJ	1	41	0.0012774177467597208	0.0016721726008401647	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	3	1	9	18	31	38	32	47														CASSSDRGAYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAAGCGGGAGGCCAACGAGCAGTACTTCGGGCCG	CASSFKREANEQYF	In	VDJ	1	47	0.0014643569292123629	0.0019168807863289693	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	1	5	2	3	18	32	43	34	46														CASSFKREANEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGTGGACAGGGGTTAAAGATGAGCAGTTCTTCGGGCCA	CASSPWTGVKDEQFF	In	VDJ	1	52	0.0016201395812562313	0.0021208042742363064	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	8	4	6	18	30	43	34	49														CASSPWTGVKDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCATAGACGGGATCAATCAGCCCCAGCATTTTGGTGAT	CASSLIDGINQPQHF	In	VDJ	1	64	0.0019940179461615153	0.0026102206452139156	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	8	3	3	8	1	18	30	43	38	44														CASSLIDGINQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGAGCGCTAGGCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	65	0.002025174476570289		55	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	18	30	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCAGGGTGGTAACTACGAGCAGTACTTCGGGCCG	CASSFQGGNYEQYF	In	VDJ	1	81	0.002523678963110668	0.003303560504098862	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	3	1	6	18	32	38	33	44														CASSFQGGNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCCGTGGCGGGTGGCGTTGAGACCCAGTACTTCGGGCCA	CASSPPVAGGVETQYF	In	VDJ	1	89	0.0027729312063808575	0.0036298380847506018	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	5	9	7	18	30	44	39	51						01,02								CASSPPVAGGVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGGCCGCCCGAAGATACGCAGTATTTTGGCCCA	CASSTGPPEDTQYF	In	VDJ	1	94	0.0029287138584247257	0.0038337615726579386	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	8	0	5	3	7	18	30	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGPPEDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTGCAGGGCCCAACTATAGCTACACCTTCGGTTCG	CASSQVAGPNYSYTF	In	VDJ	1	125	0.00389456630109671	0.005098087197683429	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	9	7	10	18	30	42	37	52														CASSQVAGPNYSYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGTGCCTATCTCGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSPSAYLGKTYGYTF	In	VDJ	1	134	0.004174975074775673	0.005465149475916636	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	8	4	1	18	18	30	35	31	53						01,02								CASSPSAYLGKTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAACCACAGGGGGCGCAGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	138	0.004299601196410768		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	0	2	5	6	18	34	48	39	54														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCCCCGTGGCGGGTGGCGTTGAGACCCAGTATTTCGGGCCA	CASSPPVAGGVETQYF	In	VDJ	1	175	0.005452392821535394	0.007137322076756801	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02			6	7	4	19	10	19	18	29	44	39	63						01,02		TCRBJ02-01,TCRBJ02-05						CASSPPVAGGVETQYF+TCRBV11-03+TCRBJ02-X	TCRBV11-03*01	TCRBD02-01	TCRBJ02	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCTCAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQAQSGANVLTF	In	VDJ	1	176	0.005483549351944167	0.007178106774338268	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	4	5	1	6	0	18	30	-1	36	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAQSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCGGACGGATCCTGGGGAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	182	0.005670488534396809		53	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	0	8	1	15	1	18	32	51	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAGGGACAGGGTGGGAGACCCAGTACTTCGGGCCA	CASSVGTGWETQYF	In	VDJ	1	191	0.0059508973080757725	0.0077898772380602796	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	3	5	0	3	18	-1	42	34	45														CASSVGTGWETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGCTACGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLRNTGELFF	In	VDJ	1	213	0.006636340977068794	0.008687140584852563	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	7	0	1	1	4	18	31	37	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGLRNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCAGACTTAATCGGAGAGACCCAGTACTTCGGGCCA	CASSFADLIGETQYF	In	VDJ	2	247	0.007695663010967099	0.010073820302622456	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	10	4	4	7	18	32	40	36	47						01,02								CASSFADLIGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGCAGGACACACCGCGAGCTTTCTTTGGACAA	CASSLRQDTPRAFF	In	VDJ	2	249	0.007757976071784646	0.010155389697785391	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	10	6	7	18	32	43	38	50														CASSLRQDTPRAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACATCGCTCGACACGACTTCCTACGAGCAGTACTTCGGGCCG	CASSTSLDTTSYEQYF	In	VDJ	2	271	0.008443419740777667	0.011052653044577674	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	2	6	1	9	5	18	30	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTSLDTTSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGCGTGGGCCTACGAGCAGTACTTCGGGCCG	CASSLEAWAYEQYF	In	VDJ	2	301	0.009378115653040878	0.012276193972021697	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	0	0	9	2	5	0	18	35	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAWAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTGAGCAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASG*AGQSRANVLTF	Stop	VDJ	1	160	0.004985044865403789		48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	5	5	5	26	39	49	44	54														CASG*AGQSRANVLTF+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATAACGAGGGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	71	0.002212113659022931		41	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	1	5	2	6	4	0	20	36	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTGGGGCCAGCCGGCACAGATACGCAGTATTTTGGCCCA	CALGPAGTDTQYF	In	VDJ	1	65	0.002025174476570289	0.0026510053427953833	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	7	0	1	2	6	23	29	36	31	42														CALGPAGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCACAGGGTGACTATGGCTACACCTTCGGTTCG	CASSPQGDYGYTF	In	VDJ	1	67	0.0020874875373878363	0.002732574737958318	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	3	3	2	23	34	43	37	45														CASSPQGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGACGCGGGGGGCCGAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	73	0.0022744267198404784		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	1	5	6	5	23	38	52	44	57														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGACGAGATTGCTGAGCAGTTCTTCGGGCCA	CASSPDEIAEQFF	In	VDJ	1	77	0.0023990528414755733	0.0031404217137729925	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	1	7	9	2	8	23	35	41	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDEIAEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTGCGGACAGCCATTTAACTATGGCTACACCTTCGGTTCG	CACGQPFNYGYTF	In	VDJ	1	84	0.002617148554336989	0.0034259145968432644	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	1	5	1	3	5	23	29	38	32	43														CACGQPFNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGACTAGCGGGAGGGGGGGAGATACGCAGTATTTTGGCCCA	CASSRTSGRGGDTQYF	In	VDJ	1	176	0.005483549351944167	0.007178106774338268	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	0	5	1	4	23	35	51	36	55														CASSRTSGRGGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGCCAGGGGAATCGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	336	0.010468594217347957		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	5	3	4	23	36	45	39	49														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGAGTCGTATAGCGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	408	0.012711864406779662		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	0	4	2	23	35	48	39	50														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGCGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSEAGGYNEQFF	In	VDJ	3	418	0.013023429710867397	0.01704800358905339	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	1	3	3	0	23	35	-1	38	46														CASSEAGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGTCCAAGTCTCCTAGTCGACAATGAAAAACTGTTTTTTGGCAGT	CASSDCPSLLVDNEKLFF	In	VDJ	3	468	0.014581256231306081	0.01908723846812676	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	8	5	11	5	23	39	54	50	59						01,02								CASSDCPSLLVDNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGAGGCTTTCGCCAAAAACATTCAGTACTTCGGCGCC	CASSYPEAFAKNIQYF	In	VDJ	4	593	0.01847582253240279	0.02418532566581019	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	11	1	1	3	5	23	38	45	41	50														CASSYPEAFAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTCGTCCGGGGAGCTGTTTTTTGGAGAA	CASSESSGELFF	In	VDJ	10	1503	0.04682826520438684	0.06129940046494555	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	2	6	0	4	23	-1	38	35	42														CASSESSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTTTGGGCCAGCAGCCCCAGCATTTTGGTGAT	CASSLLGQQPQHF	In	VDJ	1	57	0.0017759222333000996	0.0023247277621436437	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	8	0	7	4	3	24	37	45	41	48													Vb 18	CASSLLGQQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCTAACGGAGGGTAGGAGAGAGACCCAGTACTTCGGGCCA	CASLTEGRRETQYF	In	VDJ	1	60	0.0018693918245264206	0.002447081854888046	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	10	0	4	5	6	24	33	44	38	50													Vb 18	CASLTEGRRETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCAGGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPSGGGTDTQYF	In	VDJ	1	107	0.0033337487537387837	0.004363962641217015	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	1	5	0	24	38	-1	43	49													Vb 18	CASSPSGGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAATGATCACAGGGGGGAGTTCGGTTACGAGCAGTACTTCGGGCCG	CASSPNDHRGEFGYEQYF	In	VDJ	7	994	0.030969591226321036	0.04053998939597863	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	4	8	9	24	38	54	46	63													Vb 18	CASSPNDHRGEFGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3368A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				267	203	55	7	0	161	120	37	4	0	32096	24519	6708	869	0	0.102103569	6.20167255	0.0898757502	6.67204523				22028	0.0099397786	0.0612994023	0.0468282662	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:59	Age (Range):45-65 Years (Late Adulthood),Age:54 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1995,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 0,progression free survival (days):progression free survival (days) 771,treatment:nact,type of chemo:carbo/taxol	0.7602996047451176	MSKCC- Snyder- P01-01		219.0	
